Investing.com - Financial Markets Worldwide

Uni-Bio Science Group Ltd (0690)

Hong Kong
Currency in HKD
0.160
+0.007(+4.58%)
Delayed Data·
0690 Scorecard
Full Analysis
Management has been aggressively buying back shares
0690 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.1550.163
52 wk Range
0.0500.168
Key Statistics
Edit
Bid/Ask
0.159 / 0.16
Prev. Close
0.153
Open
0.155
Day's Range
0.155-0.163
52 wk Range
0.05-0.168
Volume
15.8M
Average Volume (3m)
26.33M
1-Year Change
188.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0690 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 13
Trading at a low P/E ratio relative to near-term earnings growth
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Uni-Bio Science Group Ltd Company Profile

Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China. It operates through Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products segments. The company provides BOGUTAI, a disposable injection pen for the treatment of osteoporosis; GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat invasive aspergillosis and fungal infections; and Boshutai, an oral medication for the treatment of diabetes. It also develops prescription drugs, such as UOS003(oral PTH) for the treatment of osteoporosis; Uni-GLP-1, a non-insulin treatment candidate that stimulates the incretin pathway for the treatment of type 2 diabetes and obesity; and pre-clinical stage biopharmaceutical products for wound care and ophthalmology. In addition, the company offers contract manufacture organization services. Uni-Bio Science Group Limited was incorporated in 2001 and is headquartered in Sha Tin, Hong Kong.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
487
Market
Hong Kong

Compare 0690 to Peers and Sector

Metrics to compare
0690
Peers
Sector
Relationship
P/E Ratio
11.0x26.9x−0.6x
PEG Ratio
0.510.350.00
Price/Book
2.8x2.5x2.6x
Price / LTM Sales
1.7x5.9x3.3x
Upside (Analyst Target)
-−0.9%39.5%
Fair Value Upside
Unlock10.1%4.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.01%
Dividend Yield
1.81%
Industry Median 2.10%
Annualised payout
0.00
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Apr 17, 2025
EPS / Forecast
-- / --
Revenue / Forecast
279.37M / --
EPS Revisions
a
a
Unlock
Last 90 days

0690 Income Statement

FAQ

What Stock Exchange Does Uni-Bio Science Trade On?

Uni-Bio Science is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Uni-Bio Science?

The stock symbol for Uni-Bio Science is "0690."

What Is the Uni-Bio Science Market Cap?

As of today, Uni-Bio Science market cap is 955.40M.

What Is Uni-Bio Science's Earnings Per Share (TTM)?

The Uni-Bio Science EPS (TTM) is 0.01.

From a Technical Analysis Perspective, Is 0690 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Uni-Bio Science Stock Split?

Uni-Bio Science has split 5 times.

How Many Employees Does Uni-Bio Science Have?

Uni-Bio Science has 487 employees.

What is the current trading status of Uni-Bio Science (0690)?

As of 21 Aug 2025, Uni-Bio Science (0690) is trading at a price of 0.16, with a previous close of 0.15. The stock has fluctuated within a day range of 0.16 to 0.16, while its 52-week range spans from 0.05 to 0.17.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.